Graduated in Biology from the University of Valencia in 2003. In 2006, completed the postgraduate Master’s Degree in Human Reproduction and in 2008 the Research in and Rational Use of Medicines Master’s Degree from the same university.
Presented her doctoral thesis at the Pharmacy and Pharmaceutical Technology Department of the Faculty of Pharmacy, where she collaborated as a researcher in several European projects. Obtained her Doctoral Degree from the University of Valencia in 2010.
Author and co-author of several articles in influential scientific journals, as well as different lectures in national and international conferences.
Started the project of establishing a Clinical Research Unit for the development of clinical research studies with the use of medicines at the University General Hospital of Valencia in 2010, carrying out the role of Technical Secretary of the Ethic’s Committee and of the Research Committee of said hospital.
Presently heads the Research Support and Management Unit (UAGI) at the IVI Foundation, the department in charge of giving methodological support and consultancy to all IVI researchers, and manages several training courses within the IVI Group aimed to promote research projects.
Cardiovascular Safety of Isobaric of Isobaric Levobupivacaine versus Hyperbaric Bupivacaine for Spinal Anesthesia in Patients 65 Years or Older Undergoing
Herrera R Martínez-Mir I García E Oltra D Morales-Olivas FJ
Ann Surg Perioper Care. 2016; 1(2): 1006.
Drug gastrointestinal absorption in rat: Strain and gender differences.
Oltra D Mangas-Sanjuan V González-Álvarez I Colon-Useche S González-Álvarez M Bermejo M
Eur J Pharm Sci. 2015 Oct 12;78:198-203. doi: 10.1016/j.ejps.2015.07.021. Epub 2015 Jul 28.
Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers.
Oltra D Mangas-Sanjuan V Centelles-Sangüesa A Gonzalez-Garcia I Sanchez-Castaño G Gonzalez-Alvarez M Casabo VG Merino V Gonzalez-Alvarez I Bermejo M
J Pharmacol Toxicol Methods. 2015 Jan-Feb;71: 21-32. doi: 10.1016/j.vascn.2014.11.004. Epub 2014 Nov 26.
Unique pharmacology of KAR-2, a potential anti-cancer agent: absorption modeling and selective mitotic spindle targeting.
Gonzalez-Alvarez I Gonzalez-Alvarez M Oltra D Merino V Tõkési N Ovádi J Bermejo M
Eur J Pharm Sci. 2009 Jan 31; 36(1):11-9. doi: 10.1016/j.ejps.2008.10.020. Epub 2008 Nov 5.